Blood brain barrier refers to a set of special tight junctions formed around the microvasculature of the brain to gain the optimal neural functioning. The primary function of blood brain barrier is to protect the brain from harmful toxins that are potentially present in the blood stream and allows the passage of lipid soluble, oxygen and carbon dioxide to perform the normal cellular function of brain. In a way to protect brain from noxious agents the blood brain barrier also significantly hinders the delivery of therapeutics to brain. This makes treatment of brain disorders and infections difficult due to specialized uptake of the drugs by the blood brain barrier. Recent advancement allow the drugs to be delivered directly to the cerebro-spinal fluids but are still less effective to breach the brain tissue because of tortuous nature of interstitial spaces of brain.

View Report: https://www.transparencymarketresearch.com/blood-brain-barrier-barket.html

The global market for drug delivery across the blood-brain barrier can be segmented based on:

By Technique Invasive techniques Intra-cerebro-ventricular infusion Intra-cerebral injections Catheter implant into brain parenchyma Physiological techniques Transporter mediated delivery Receptor mediated delivery Nanoparticle coated delivery Liposomes coated delivery Pharmacological approach By Disease Type Alzheimer\’s Sleep disorder Multiple sclerosis Epilepsy Cerebral abscess Meningitis

The global market for drug delivery across the blood brain barrier is still emerging under the influence of rise in central nervous system disorders and growing need for targeted drug delivery. Use of several transport enzymes and receptors such as human insulin receptors, transferrin receptors and nanoparticles combined drug is expected to drive this market in the coming years. Significant developments in programmable infusion devices and discovery of various non-conventional route of brain drug administration such as nasal delivery will enhance the adoption and recognition of devices and techniques.

Some of the key players in this market include Ablynx NV, AngioChem, Inc., Bioasis Technologies, Inc., Cognition Pharmaceuticals LLC,Diamedica, Inc., Pfizer andRoche Pharmaceuticals.

Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1833

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America
Asia Pacific
Europe
Rest of the World

This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

Request TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=1833

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com